Dominican Republic claims 16% cost advantage over China in MedTech market
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
What happened
The Dominican Republic presented evidence at The MedTech Conference in Boston showing that it offers a 16.0% total-cost advantage over China for medical devices supplied to the United States, even after accounting for a 12.5% U.S. tariff. For a modeled annual program of 5.25 million units, the total cost is US$23.33 per unit from the Dominican Republic compared to US$27.76 per unit from China, once tariffs, inventory, quality management, and supply-chain risk are included.
From chathamdailynews.ca
Why it matters
The findings suggest that proximity and cost advantages could accelerate supply chain shifts for medical devices into the Dominican Republic. This shift is presented as a solution to the pressures created by tariffs and supply chain risks.
From chathamdailynews.ca
Who's involved
- Dominican RepublicThe island sovereign state offering a competitive cost advantage in medical device manufacturing.
- BostonThe location where the delegation presented the findings at a major MedTech conference.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- FDASpeculative
The FDA might require regulatory review and adaptation of standards due to new supply chains originating from the Dominican Republic.
- American AirlinesSpeculative
American Airlines could see increased demand for air cargo services as supply chains shift to the Dominican Republic.
Keep exploring
The entities involved
-
Dominican Republic
island sovereign state in the Caribbean Sea
-
Boston
capital and largest city of Massachusetts, United States